Oruka Therapeutics SVP Finance Arjun Agarwal reports disposal of $800,089 in common shares
ORKA•Oruka Therapeutics SVP of Finance Arjun Agarwal exercised options for 9,999 shares on Oct. 12, 2026, then sold all 9,999 shares. The disposal was valued at $800,089, and his beneficial ownership ended at 14,219 shares.
1. Option exercise and sale
Arjun Agarwal exercised options for 9,999 Oruka Therapeutics shares on Oct. 12, 2026. The exercise prices were $12.50 for 8,541 shares and $34.39 for 1,458 shares. He sold all 9,999 shares that day at weighted average prices ranging from $80.0302 to $82.835, and his beneficial ownership ended at 14,219 common shares.
